IRIS
PERLINI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.405
AS - Asia 5.205
EU - Europa 4.928
SA - Sud America 612
AF - Africa 76
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 18.256
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.242
CN - Cina 2.730
SG - Singapore 1.223
IE - Irlanda 1.167
RU - Federazione Russa 683
HK - Hong Kong 648
DE - Germania 585
UA - Ucraina 578
IT - Italia 540
FI - Finlandia 538
BR - Brasile 506
GB - Regno Unito 239
SE - Svezia 237
VN - Vietnam 211
CA - Canada 94
FR - Francia 91
IN - India 79
JP - Giappone 62
BE - Belgio 56
MX - Messico 50
PL - Polonia 44
TR - Turchia 43
AR - Argentina 42
ZA - Sudafrica 39
ES - Italia 29
BD - Bangladesh 28
CZ - Repubblica Ceca 26
IR - Iran 26
NL - Olanda 26
AT - Austria 24
IQ - Iraq 24
ID - Indonesia 20
LT - Lituania 17
AU - Australia 16
EC - Ecuador 14
PY - Paraguay 13
PK - Pakistan 12
UZ - Uzbekistan 12
VE - Venezuela 11
SA - Arabia Saudita 10
CL - Cile 9
CO - Colombia 9
MA - Marocco 9
IL - Israele 7
LB - Libano 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
EG - Egitto 6
JM - Giamaica 6
JO - Giordania 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
AM - Armenia 5
CH - Svizzera 5
DZ - Algeria 5
GR - Grecia 5
KG - Kirghizistan 5
LV - Lettonia 5
AL - Albania 4
BH - Bahrain 4
KZ - Kazakistan 4
PH - Filippine 4
UY - Uruguay 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
EU - Europa 3
MU - Mauritius 3
MY - Malesia 3
NO - Norvegia 3
PE - Perù 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MK - Macedonia 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
SN - Senegal 2
TM - Turkmenistan 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
ET - Etiopia 1
GD - Grenada 1
Totale 18.243
Salva come PNG Salva come JPEG
Città #
Chandler 1.233
Dublin 1.165
Jacksonville 733
Dallas 731
Hong Kong 639
Singapore 564
Nanjing 557
Beijing 530
Ashburn 520
Boardman 351
Ann Arbor 243
Princeton 220
Nanchang 218
Lawrence 210
Wilmington 210
Los Angeles 195
Helsinki 181
Shenyang 164
Hebei 160
Munich 152
Medford 146
Changsha 138
Moscow 137
New York 135
Milan 131
Jiaxing 111
Redondo Beach 111
Pavia 100
Buffalo 95
Shanghai 93
Tianjin 84
Ho Chi Minh City 81
Hangzhou 76
Turku 66
Tokyo 58
Brussels 56
São Paulo 55
Woodbridge 51
Hanoi 42
Norwalk 41
Toronto 41
Seattle 39
Falls Church 36
Falkenstein 34
Saint Petersburg 34
Warsaw 34
Brooklyn 32
London 31
Verona 31
Guangzhou 30
Chicago 29
Fairfield 29
Santa Clara 29
The Dalles 29
Boston 28
Nuremberg 27
Montreal 26
Johannesburg 25
Brno 23
Frankfurt am Main 23
Houston 23
Mexico City 22
Zhengzhou 22
San Francisco 21
Stockholm 21
Denver 20
Chennai 19
Phoenix 19
Piscataway 18
Columbus 17
Des Moines 16
Jinan 16
Rio de Janeiro 16
Taizhou 16
Atlanta 15
Manchester 15
Pune 15
Orem 14
Kunming 13
Poplar 13
Washington 13
Amsterdam 12
Secaucus 12
Vienna 12
Çanakkale 12
Auburn Hills 11
Tashkent 11
Vicenza 11
Ankara 10
Council Bluffs 10
Düsseldorf 10
Mumbai 10
Ningbo 10
Rome 10
Baghdad 9
Biên Hòa 9
Charlotte 9
Curitiba 9
Dhaka 9
Haiphong 9
Totale 11.952
Salva come PNG Salva come JPEG
Nome #
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance 141
Valore prognostico della presenza di bassi voltaggi elettrocardiografici nei pazienti affetti da amiloidosi AL 130
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 130
Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure. 129
Fibrillazione atriale e amiloidosi cardiaca AL: un connubio intrigante 128
La simulazione su manichino migliora l’abilità degli studenti di Medicina nell’auscultazione cardiaca? L’esperienza di Pavia 126
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 126
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers. 122
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 120
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 119
Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation. 117
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 117
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. 116
Treatment of chronic heart failure: an expert system advisor for general practitioners. 116
Effect of chronic sympatectomy in a model of rat cardiac hypertrophy: role of the extracellular matrix. 113
Adenosine 113
Remote matrix metalloproteinases activation as systemic consequence pf liver injury: the role of lung. 113
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 113
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 112
Experience from controlled trials of physical-training in chronic heart-failure-protocol and patient factors in effectiveness in the improvement in exercise tolerance 108
Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium 108
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 108
Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. 107
Direct renin inhibition: another weapon to modulate the renin-angiotensin system in postinfarction remodeling? 107
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 107
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 106
Alterations in Early Filling Dynamics Predict the Progression of Compensated Pressure Overload Hypertrophy to Heart Failure Better than Abnormalities in Midwall Systolic Shortening 105
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 105
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 104
Adherence of the guidelines in an Italian ED in case of minor head trauma (MHI) in real life 104
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients 103
Comparative analysis of a 4-lead portable smartphone based electrocardiograph versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 103
Interstitial fibrosis is blunted by chronic sympathectomy in experimental pressure-overload hypertrophy. 103
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 103
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 103
Analisi preliminare di un sistema esperto per la diagnosi cardiologica incruenta. 100
A multimarker study of degenerative aortic valve disease: Stenoinsufficiency shows more indices of bad prognosis 100
Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors? 99
Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System 99
Simulation-guided cardiac auscultation improves medical students' clinical skills: the Pavia pilot experience 98
Autonomic and ventilatory components of heart rate and blood pressure variability in freely behaving rats. 98
Effects of the chronic digoxin administration on extracellular matrix turnover in a model of cardiac hypertrophy in Guinea pigs. 97
Right ventricular function in AL amyloidosis: characteristics and prognostic implication 96
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 94
Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis 93
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. 93
Lung Matrix Metalloproteinase Activation following Partial Hepatic Ischemia/Reperfusion Injury in Rats 92
Effects of a Bioavailable Arabinoxylan-enriched White Bread Flour on Postprandial Glucose Response in Normoglycemic Subjects 92
Valore prognostico della presenza di disturbi della conduzione cardiaca nei pazienti affetti da amiloidosi AL 91
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 91
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 91
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis 90
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. 89
The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44 89
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 89
Antiadrenergic effects of adenosine in pressure overload hypertrophy. 88
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure 88
Lack of contribution of autonomic influences to vascular nitric oxide release? Studies in the unanesthetized rat. 88
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 88
Matrix metalloproteinases: analysis of the activity in Guinea pig cardiac hypertrophy. 87
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 87
Thalidomide plus intermediate-dose dexametasone is an effective but toxic treatment for patients with AL (primary) amyloydosis 87
Assessment of regional myocardial performance with end-systolic pressure lenght and thickness relationships. 87
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 87
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 87
Machine-Learning-Based COVID-19 and Dyspnoea Prediction Systems for the Emergency Department 86
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 85
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies 85
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 85
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL amyloidosis 84
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 84
Evaluation of matrix metalloproteases activity in Guinea pig cardiac hypertrophy. 84
Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19 84
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 84
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 83
QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine 83
Ultrasonic integrated backscatter as a useful and tool to noninvasively study myocardial function and fibrosis in hypertensive heart disease 82
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 82
Le alterazioni della dinamica del riempimento ventricolare sinistro predicono la progressione dell'ipertrofia ventricolare sinistra verso l'insufficienza cardiaca. 82
As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis 82
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 81
Reproducibility of ultrasound assessment of common carotic and femoral artery compliance and distensibility in the anesthetized rat. 80
Semplice algoritmo per la valutazione del rilasciamento isovolumetrico del ventricolo sinistro. 80
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients 80
Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis 80
Prevalence and Prognostic Value of Conduction Disturbances at the Time of Diagnosis of Cardiac AL Amyloidosis 79
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 79
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis 79
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 79
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 79
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 79
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 78
Hypertensive heart disease: diagnostic and therapeutic guidelines.Commissione congiunta Società Italiana dell'lpertensione Arteriosa; Società Italiana di Cardiologia; Associazione Nazionale Medici Cardiologi Ospedalieri. 78
Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event 78
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis 78
Confronto tra apicografia calibrata e tecniche invasive della valutazione della diastole: dati preliminari. 78
Determinants of respiratory sinus arrhythmia in the vagotomized rabbit. 77
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers 77
Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? 77
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 77
Totale 9.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.275
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021776 0 0 0 0 0 140 22 199 66 175 144 30
2021/20221.017 19 15 38 16 39 36 31 71 61 31 153 507
2022/20233.398 379 240 51 296 350 350 3 184 1.392 17 90 46
2023/20241.268 164 201 47 86 116 292 38 75 10 60 83 96
2024/20253.836 129 278 74 162 93 220 219 233 928 142 437 921
2025/20264.314 643 621 924 975 1.066 85 0 0 0 0 0 0
Totale 18.561